ArticleDevelopmental medicine and child neurology2022

Niemann-Pick type C disease as proof-of-concept for intelligent biomarker panel selection in neurometabolic disorders.

Apostolos Papandreou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.